• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down3.39% Nasdaq Down4.12%

    More On BIOCON.NS



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Biocon Limited (BIOCON.NS)

    710.60 Down 8.70(1.21%) Jun 24, 6:00AM EDT
    ProfileGet Profile for:
    Biocon Limited
    20th KM, Hosur Road
    Electronics City
    Bengaluru, 560100
    India - Map
    Phone: 91 80 2808 2808
    Fax: 91 80 2852 3423
    Website: http://www.biocon.com

    Index Membership:N/A
    Full Time Employees:8,234

    Business Summary 

    Biocon Limited, an integrated healthcare company, develops and sells biotechnology products for the pharmaceutical sector in India and internationally. It offers active pharmaceutical ingredients, including cardiovascular agents, anti-obesity agents, immunosuppressants, and narrow spectrum antibiotics; and biosimilars comprising human insulin, insulin glargine, insulin lispro, insulin aspart, and monoclonal antibodies. The company also provides branded formulations in the areas of metabolics, oncotherapeutics, nephrology, comprehensive care, immunotherapeutics, and virology; and out-licensing services. In addition, it offers contract manufacturing services, including mammalian fermentation, human insulin and biosimilars, microbial cell culture, and chemical synthesis; undertakes clinical research activities on discovering new biomarkers; and provides integrated contract research services to support discovery and development for small and large molecules. The company’s principal brands include INSUGEN, BASALOG, BIOMAb EGFR, CANMAb, and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It serves its customers in approximately 120 countries. The company was founded in 1978 and is headquartered in Bengaluru, India.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Biocon Limited

    Key Executives 
    Ms. Kiran Mazumdar-Shaw B.Sc (Hons), PGD in Malting & Brewing, 63
    Founder, Chairman, Managing Director and Member of Share Transfer Committee
    Dr. Arun Suresh Chandavarkar B.Tech., M.S., Ph.D.(Chemical Eng.), 55
    Chief Exec. Officer, Joint Managing Director and Exec. Director
    Mr. John Mccallum Marshall Shaw M.A (Hons), 67
    Vice Chairman and Member of Share Transfer Committee
    Mr. Siddharth Mittal BCom, CA, CPA, 38
    Chief Financial Officer and Pres of Fin.
    Mr. G. Kiran Kumar ,
    Assistant VP of Fin., Compliance Officer and Company Sec.
    Amounts are as of Dec 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in INR.